In this report, 100 specialists—including rheumatologists, dermatologists, and immunologists—share how the new $2K out-of-pocket cap is influencing treatment choices, patient access, and perceptions of manufacturer support. The findings reveal both progress and persistent barriers, offering a data-driven look at how affordability reform is redefining access, trust, and innovation in specialty care.
Download the report now!